Ortho Clinical Diagnostics was a global in vitro diagnostics (IVD) company serving hospitals, clinical laboratories and blood banks for more than 80 years before merging with Quidel Corporation in 2022 to form QuidelOrtho. [1] Its visual identity evolved through several ownership phases, from a Johnson & Johnson subsidiary to an independent Carlyle Group company and eventually a publicly traded firm on Nasdaq.
Design and History
Ortho Clinical Diagnostics traces its corporate identity to Ortho Diagnostic Systems, which filed a trademark for the “Ortho-Clinical Diagnostics & Caduceus” mark in 2002. [2] An earlier US trademark registration from 1999 for “ORTHO-CLINICAL DIAGNOSTICS” also included a caduceus symbol, the serpent-and-staff medical emblem. [3]
In 2014, The Carlyle Group completed its acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for approximately $4 billion, returning the business to independent operation. [4] Following this transition, the company pursued a brand evolution. The Bain Group documented its work re-engineering the Ortho brand, describing the challenge of organizing “layered chaos of years of one-off brand solutions.” The rebrand combined existing brand equity with new fonts, revamped colors and purposeful graphical brand elements, anchored by the messaging platform “Because Every Test is a Life™.” [5]
Ortho Clinical Diagnostics later filed a new trademark for the word mark “ORTHO CLINICAL DIAGNOSTICS” in July 2016, registered in April 2017. [6] The company went public on Nasdaq in January 2021 under the ticker OCDX. [7]
In May 2022, Quidel Corporation and Ortho Clinical Diagnostics completed their business combination, creating QuidelOrtho Corporation. [8] The Ortho Clinical Diagnostics brand was subsequently retired in favor of the new QuidelOrtho identity.
Meaning and Symbolism
Ortho’s pre-2014 identity under Johnson & Johnson used the caduceus, a traditional medical symbol featuring a serpent entwined around a staff. [3] The company’s later brand evolution under Carlyle ownership emphasized patient-focused messaging rather than symbolic imagery. The Bain Group noted that the rebrand prioritized “consumer-styled imagery that remained B2B2C patient-focused, yet not product-focused,” positioning Ortho as an organization driven to do what is best for patients. [5]
Corporate office design for Ortho Clinical Diagnostics used red as the company’s principal color, complemented by blue tones and geometric motifs. [9]
Typography and Design
The Bain Group’s rebrand work for Ortho Clinical Diagnostics introduced new fonts and revamped colors as part of a strategic visual and messaging framework developed in collaboration with Ortho’s internal brand and communications team. [5] Specific typeface names and exact color specifications were not publicly documented.
After the QuidelOrtho merger, Siegel+Gale designed a new brand identity for the combined company. The QuidelOrtho logo mark uses stylized versions of the letters Q and O, constructed from rounded squares described as “both mathematical and organic,” with a customized variable font delivering 16 typographic styles. [10] This identity replaced the Ortho Clinical Diagnostics brand entirely.
Logo Index is an independent educational archive covering logos, visual identities and graphic design history. All trademarks and brand assets remain the property of their respective owners.
